Q32 Bio (QTTB) Receivables - Net (2018 - 2021)

Q32 Bio's (QTTB) quarterly Receivables - Net came in at $100000.0 in Q3 2021, down 75.0% year-on-year from $400000.0 in Q3 2020, and down 50.0% quarter-over-quarter from $200000.0 in Q2 2021.

Q32 Bio (QTTB) Receivables - Net (2018 - 2021) Analysis & Trends

Q32 Bio's Receivables - Net history runs 4 years deep, the most recent figure standing at $100000.0 for Q3 2021.

  • On a quarterly basis, Receivables - Net fell 75.0% year-over-year to $100000.0 in Q3 2021; TTM through Sep 2021 was $100000.0, a 75.0% decrease from a year earlier, with the FY2020 full-year figure at $400000.0, changed 0.0% from the prior year.
  • Receivables - Net fell to $100000.0 in Q3 2021 per QTTB's latest filing, from $200000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $800000.0 in Q4 2018 and bottomed at $100000.0 in Q3 2021.
  • The 4-year median for Receivables - Net is $350000.0 (2019), against an average of $350000.0.
  • Across the five-year window, Receivables - Net jumped 100.0% in 2020 and sank 75.0% in 2021, its largest moves.
  • Year by year, Receivables - Net stood at $800000.0 in 2018, then sank by 50.0% to $400000.0 in 2019, then changed by 0.0% to $400000.0 in 2020, then sank by 75.0% to $100000.0 in 2021.
  • Per Business Quant, the three latest QTTB Receivables - Net figures stand at $100000.0 (Q3 2021), $200000.0 (Q2 2021), and $300000.0 (Q1 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Q32 Bio 225.00 Mn 174.25 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2021 100,000.00
Sep 30, 2021 100,000.00
Jun 30, 2021 200,000.00
Jun 30, 2021 200,000.00
Mar 31, 2021 300,000.00
Mar 31, 2021 300,000.00
Dec 31, 2020 400,000.00
Dec 31, 2020 400,000.00
Sep 30, 2020 400,000.00
Sep 30, 2020 400,000.00
Jun 30, 2020 400,000.00
Jun 30, 2020 400,000.00
Mar 31, 2020 400,000.00
Mar 31, 2020 400,000.00
Dec 31, 2019 400,000.00
Dec 31, 2019 400,000.00
Sep 30, 2019 300,000.00
Sep 30, 2019 300,000.00
Jun 30, 2019 300,000.00
Jun 30, 2019 300,000.00